Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in ChinaYuankai Shi, Jingwen Wang, Lugui Qiu et al.|Journal of Hematology & Oncology|2017Cited by 256
MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cellsZhong Zheng, Weili Zhao|Molecular Cancer|2019Cited by 134
Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progressionWeili Zhao, Anne Janin|Laboratory Investigation|2004Cited by 103
Therapeutic targeting miR130b counteracts diffuse large B-cell lymphoma progression via OX40/OX40L-mediated interaction with Th17 cellsRui Sun, Weili Zhao|Signal Transduction and Targeted Therapy|2022Cited by 53
Doxorubicin-loaded dextran-based nano-carriers for highly efficient inhibition of lymphoma cell growth and synchronous reduction of cardiac toxicityYing Fang, Weili Zhao|International Journal of Nanomedicine|2018Cited by 39